Empyrean Therapeutics, Inc. | Finanzwire

Basculer en Français

8313	Companies
115785	Keywords
55890	Articles
62791	Press releases

Headlines Articles Press releases Empyrean Therapeutics, Inc.

Home
Companies
Empyrean Therapeutics, Inc.

BRIEF

published on 11/25/2024 at 23:25, 4 hours 9 minutes ago

Empyrean Therapeutics Acquires Novel Cancer Treatment Molecule

Cancer Treatment Pharmaceutical Acquisition Empyrean Therapeutics TLR-2 Antagonist R&D Innovation
PRESS RELEASE

published on 11/25/2024 at 23:20, 4 hours 14 minutes ago

Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment
Empyrean Therapeutics, Inc. acquires novel cancer drug molecule EMS-312 from Eos Therapies, aiming to expedite development for brain, pancreatic, breast, and hard-to-treat cancers. Strategic move marks milestone. CEOs Kal Fishman and Doug Bonhaus express optimism

Empyrean Therapeutics Novel Cancer Drug EMS-312 Eos Therapies CEO Kal Fishman

Accesswire

Published on 11/26/2024 at 02:15, 1 hour 19 minutes ago

Alphinat Awarded Contract SSO Platform for an Ontario Municipality
Published on 11/26/2024 at 01:00, 2 hours 34 minutes ago

FE Battery Metals Corp. Commences 2024 Winter Drilling Program
Published on 11/26/2024 at 00:37, 2 hours 57 minutes ago

CORRECTION; CoTec Holdings Corp. Announces Convertible Loan Agreement
Published on 11/26/2024 at 00:20, 3 hours 14 minutes ago

NexgenRx Announces Third Quarter Results and Declaration of Divdend
Published on 11/26/2024 at 00:00, 3 hours 34 minutes ago

Medicure Reports Financial Results For Quarter Ended September 30, 2024

View all ACCESSWIRE

EQS Group

Published on 11/25/2024 at 20:35, 6 hours 59 minutes ago

Launch of World Advanced Manufacturing & Logistics Expo & Summit (WAM Morocco) 2025 to Advance the Country’s Shift Towards Next-Generation Industries and High-Value Manufacturing
Published on 11/25/2024 at 20:34, 7 hours ago

Avolta wins new ten-year contract, adds Manaus Airport to Brazil portfolio
Published on 11/25/2024 at 18:55, 8 hours 39 minutes ago

Molten Ventures Plc: HOL-Holding(s) in Company
Published on 11/25/2024 at 18:27, 9 hours 7 minutes ago

Annual General Meeting 2024 - Approval of all agenda items / Dividend / Election of the Supervisory Board
Published on 11/25/2024 at 18:24, 9 hours 10 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 11/25/2024 at 17:55, 9 hours 39 minutes ago

Disclosure of trading in own shares from 18/11/2024 to 22/11/2024
Published on 11/25/2024 at 17:45, 9 hours 49 minutes ago

Reporting on share buyback transactions carried out between November 19 and November 22, 2024
Published on 11/25/2024 at 17:45, 9 hours 49 minutes ago

Disclosure of trading in own shares from November 18th, 2024, to November 22th, 2024. Detailed information per transaction
Published on 11/25/2024 at 17:45, 9 hours 49 minutes ago

Disclosure of trading in own shares from November 18th, 2024, to November 22th, 2024.
Published on 11/25/2024 at 17:45, 9 hours 49 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE